Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already ...

In clinical trials, weight loss with GLP-1 medications tends to follow a predictable curve: rapid early losses during drug ...

Swiss drugmaker’s CEO says launch of weight loss pill has been ‘one of the most successful pharmaceutical debuts ever’ ...

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of ...

After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched ...